Enbrel Biosimilar Gets Green Light
Enbrel's new biosimilar recently got the green light it needed to treat several inflammatory health conditions.
Inflammatory Disease Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved a new medication to treat multiple chronic inflammatory diseases.
Another Biosimilar Gets a Green Light
The US Food and Drug Administration (FDA) has approved another biosimilar. This one is meant to treat multiple conditions that affect the immune system.
Green Light for Biosimilar to Humira
The US Food and Drug Administration has approved its fourth biosimilar.
FDA Approves First Biosimilar Etanercept
The US Food and Drug Administration (FDA) has approved the first biosimilar etanercept.
Second Biosimilar Gets FDA Nod
The US Food and Drug Administration (FDA) has approved the second-ever biosimilar, and it's meant to treat multiple conditions that affect the immune system.
Anti-TNFs Not to Blame for Skin Infections in RA
Anti-TNF medications used to control arthritis symptoms have been linked to increased risks for skin infections. However, a recent study has shown that this may not necessarily be true.
No Safety Surprises from Humira
Humira (adalimumab) is a medication used to treat a variety of diseases. As the medication is being prescribed to more and more patients, researchers wanted to see if there were any side effects they didn't know about before.
Shingles Vaccine Safe for More Patients
People taking immunity-suppressing drugs are currently advised against the live-virus shingles vaccine because there is concern that it could lead to shingles, for this population.
In Need of Vitamin D
Sitting in the sun can help you get healthy doses of vitamin D. But it seems some people with a certain form of arthritis are not getting enough of the sun's rays.